Columns

If you’re anything like me, your ankylosing spondylitis (AS) diagnosis may not have been the easiest thing in the world to reconcile. Being diagnosed with a lifelong, degenerative, chronic illness can be a wake-up call unlike any other. Feelings of depression, powerlessness, confusion, and denial can surge through you,…

Life with ankylosing spondylitis is full of ups and downs influenced by good days and bad days, endless fatigue, doctor’s appointments, and the general trickiness of managing a chronic illness with life’s other demands. The unpredictable nature of fatigue accounts for missed days at work and canceled social gatherings. There’s…

The European Medicines Agency has accepted for review Lupin‘s marketing authorization application for YLB113, a biosimilar of etanercept that is marketed by Amgen under the brand name Enbrel. YLB113’s application is for the treatment of ankylosing spondylitis, axial spondyloarthritis, and non-radiographic axial spondyloarthritis, as well as rheumatoid and psoriatic arthritis…

Having a great foundation and support system is vital to the success of anything mighty you are trying to achieve. Being diagnosed with ankylosing spondylitis (AS) is no different. In fact, it is probably even more important to have a strong foundation of support and community. One of the main…

I think it’s safe to say, heading into the New Year, that we all have goals we plan to accomplish. I recommend letting the old things pass away and starting anew. Sure, we still will deal with doctor’s appointments and we still have ankylosing spondylitis (AS) or axial…